Tamara Costas Caamaño

Title: Tamara Costas Caamaño: Innovator in Selective MAO-B Inhibitors

Introduction

Tamara Costas Caamaño is a notable inventor based in Vigo, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of selective inhibitors for monoamine oxidase isoform B (MAO-B). Her work is particularly relevant for treating neurodegenerative disorders.

Latest Patents

Tamara holds a patent for "Pyridazin-3(2H)-one derivatives as monoamine oxidase selective isoform B inhibitors." This invention focuses on pyridazin-3(2H)-one derivatives that are selective MAO-B inhibitors. These compounds are designed to treat disorders associated with MAO-B hyperactivity, such as Parkinson's disease, Alzheimer's disease, and other dementias. The derivatives feature dithiocarbamate moieties bonded to specific positions through alkyl chains of varying lengths.

Career Highlights

Throughout her career, Tamara has worked with esteemed institutions, including the Universidade de Vigo and the Universidade de Santiago de Compostela. Her research has been instrumental in advancing the understanding of MAO-B inhibitors and their potential therapeutic applications.

Collaborations

Tamara has collaborated with notable colleagues, including Ma Del Carmen Terán Moldes and Pedro Besada Pereira. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Tamara Costas Caamaño is a pioneering inventor whose work on selective MAO-B inhibitors holds promise for treating serious neurodegenerative diseases. Her contributions to medicinal chemistry continue to impact the field positively.